Omar Oakes
May 8, 2018

GSK reviews global media

Pharma giant GlaxoSmithKline has reportedly launched a review of its US $1.8 billion global media agency arrangements, putting MediaCom and PHD on alert.

GSK reviews global media

The review, which is being handled by ID Comms, comes less than three years after GSK awarded its European business to MediaCom, while PHD was handed its US media account.

Both agencies had retained the accounts in 2015 following a global media review, after having been first appointed in 2013.

A year later, GSK completed an agency review for the other parts of its marketing comms business by hiring nine agencies, including Grey and Saatchi & Saatchi for advertising.

GSK's agencies were appointed to work on the company's seven power brands (Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Theraflu and Otrivin) and 12 core brands (Biotene, Contac, Flonase, Excedrin, Fenbid, Tums, ENO, Horlicks, Physiogel, Lamisil, Fenistil and Abreva/Zovirax).

GSK did not respond to a request for comment by Campaign UK by press time while MediaCom and PHD would not comment and referred Campaign to GSK.

Source:
Campaign UK

Related Articles

Just Published

4 hours ago

Cannes Lions, AI, and the integrity reckoning

The first ever Cannes Lions Grand Prix withdrawal for AI misuse signals a watershed moment, but is this just the beginning of a much bigger reckoning for marketing in the AI age?

5 hours ago

Wrangles in the jury room: how the challenges of ...

Tricky deliberations, outside influences and questionable entries can make the quest to recognise the best work with an award a difficult one.

5 hours ago

Bacardi picks agencies for trio of global creative ...

AMV was the incumbent on Bombay Sapphire's account and BBDO held the Bacardi Rum and St Germain accounts.

18 hours ago

AI, Asia, and the new CMO

Five takeaways from Cannes Lions 2025.